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Functional T  cell clones have been useful in defining the specificity of the T 
cell recognition  repertoire  at  multiple  levels (1).  Their  use has confirmed  the 
importance of the major histocompatibility complex (MHC)  1 in cellular interac- 
tions  involving  the  recognition  of foreign antigens  (2,  3).  A  number  of gene 
products that are encoded for by loci outside the MHC region may also play a 
role in  lymphocyte interactions.  The  Mls locus encodes for determinants  that 
induce T  lymphocyte proliferation  and  is a  candidate  for such involvement in 
the recognition of antigen. 
Recently, individual  T  cell clones have been isolated that proliferate to both 
syngeneic MHC and allogeneic Mls determinants  (4, 5).  The nature of this Mls 
recognition and its function in the immune response have not been determined. 
The Mls locus has been mapped to chromosome 1 and is linked to the dipeptidase- 
1 gene (6).  Gene products of two Mls alleles, Mls  a and Mls  a, generate a primary 
mixed  lymphocyte response  (MLR) of equal  magnitude  to  that  generated  by 
MHC determinants.  The two other alleles, Mls  b and Mls  c, can usually be detected 
only in  a  secondary  MLR.  Recognition  of allogeneic  Mls determinants  in  the 
MLR has been shown to occur in association with "self" MHC determinants (7, 
8).  The high  frequency of virgin T  ceil-bearing receptors for Mls suggests that 
these determinants may play a role in T  cell responsiveness. 
The present study was undertaken to characterize a T  cell clone selected for 
its ability to  proliferate  in  the  presence  of syngeneic  Mls  b determinants.  The 
results  presented  suggest  that  syngeneic  MIs  gene  products  expressed  on  B 
lymphocytes and  antigen-presenting  cells may act  in  a  manner  similar  to  H-2 
gene products in antigen presentation to T  lymphocytes. 
Materials and Methods 
Mice.  BALB/c,  C57BL/6,  CB6/Fb  CBA/J,  B10.D2,  and  Rill,  6-8-wk-old,  were 
purchased from The Jackson Laboratory, Bar Harbor,  ME. BXD recombinant inbred 
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strains were derived from the cross between C57BL/6 (H-2 b, Mls  b) and DBA/2 (H-2 d, 
M  lsa). All BX D strains were supplied by Dr. Benajamin Taylor of The Jackson Laboratory. 
AB.Y  mice were obtained from the  colony of Dr.  David  Meruelo of the  New  York 
University School of Medicine. BALB.B and BALB.K were provided by Dr.  Maurice 
Zuaderer, Columbia University, New York. 
Antigens.  Keyhole limpet hemocyanin (KLH) (Calbiochem-Behring Corp., San Diego, 
CA)  and  ovalbumin  (OVA)  (Sigma  Chemical  Co.,  St.  Louis,  MO)  were  conjugated 
separately with 2,4,6-trinitobenzene sulfonic acid (Eastman Kodak Co., Rochester, NY) 
in 0.83  M sodium bicarbonate buffer and then dialyzed against 0.1  M potassium bicar- 
bonate buffer. Horse cytochrome c (Sigma Chemical Co.) and an isolate of type A influenza 
virus, PR8, were used as control antigens. 
Monoclonal Antibodies.  Hybridoma cell lines with defined specificities for I-A  b (25-9-3s) 
and I-A  d (MK-D6) were purchased from the American Type Culture Collection, RockviIle, 
MD. Ascites of anti-Lyt-l.2 and anti-Lyt-2.2 were purchased from New England Nuclear, 
Boston, MA. Ascites of hybridoma 30-H 12 (anti-Thy-l.2) and  10.2-16  (anti-I-A k) were 
generously provided by Dr. Benvenuto Pernis, Columbia University. All anti-I-A ascites 
used in T  cell proliferative blocking experiments were precipitated with 50% saturated 
ammonium sulfates and purified by ion exchange chromatography. 
Preparation of T Cell Clones.  Lymph node T  lymphocytes were obtained from CB6/F~ 
mice primed  with  100  ug  KLH  in  Freund's  complete  adjuvant (Difco  Laboratories, 
Detroit, MI).  The mice were injected subcutaneously in the base of the tail and in the 
hind foot pads. 7 d later, T cells from the periaortic, popliteal, and inguinal lymph nodes 
were purified on a nylon wool column (9). 
The KLH-reactive T  cells were further enriched by culturing the nonadherent popu- 
lation from the nylon wool column with 50 t~g KLH/ml for 4 d in T  cell medium (RPMI 
1640, containing 10% fetal calf serum [Reheis Chemical Co., AZ],  12 mm Hepes, 100 #1 
penicillin, 100 mg[ml streptomycin, 2 x  10  -s M glutamine, and 3 x  10  -5 M 2-mercapto- 
ethanol). After 4 d of incubation, at 37°C and 7% COs, lymphoblasts were isolated and 
established as long-term T  cell lines (10,  11). 
Proliferation Assays.  All T  cell clones and subclones were tested for proliferation to a 
panel of soluble protein antigens and in mixed lymphocyte cultures. 7 d after subculture 
without antigen, 10  ~ cloned T  cells and 5 x  105 irradiated syngeneic or allogeneic spleen 
cells were cultured in 0.2 ml microtiter wells. After 3 d, the cultures were pulsed with 
[SH]thymidine (1 #Ci/well) and harvested 18 h later. No exogenous interleukin 2 (IL-2) 
was added to the cultures. All responses were measured in triplicate cultures. T cell clones 
were proven to be monoclonal by the performance of proliferation studies in the presence 
of bromodeoxyuridine (BUdR) and subsequent exposure to light. 
Results 
Several T  cell clones were derived from lymph nodes of CB6/F1 mice primed 
with KLH. After subcloning by limiting dilution, one subclone, A9.4, exhibited 
the unique property of responding to KLH in the presence of irradiated synge- 
neic  CB6/FI  spleen  cells,  as  well  as  spleen  cells  from  either  parental  strain 
(BALB/c and  C57BL/6).  This  subclone has been  maintained in  culture for a 
period of 18 mo and proliferates in response to KLH, but not to control antigens 
cytochrome c or PR8 (data not shown). Subcione A9.4 was shown to express the 
phenotype, Thy 1.2 +, Lyt 1  +, and Lyt 2-. 
Subclone  A9.4  was  maintained in  RPMI  1640  medium  supplemented  with 
fetal calf serum. Therefore, the proliferative response of this clone was studied 
to assess whether it could result from proteins contained in fetal calf serum that 
had  become  associated  with  MHC  determinants  on  antigen-presenting  cells. 
Experiments designed to examine this possibility showed that A9.4 cells prolif- 
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TABLE  I 
Proliferation of A9.4 Subclone in Culture Medium Supplemented with Serum from Different Origin 
[SH]Thymidine incorporation (cpm) 
Origin of 
serum added  CB6FI cells*  BALB/c cells  C57BL/6 cells 
to culture*  Medium 
Nil  KLH  Nil  KLH  Nil  KLH 
Fetal calf(5%)  75 +  16!  4,073 _+ 22  20,644_+ 846  3,970 _+ 410  19,826 _+ 589  3,944_+ 66  19,714 +  68 
Horse (5%)  66 _+ 2  2,891 _+ 32  14,070 +  42  2,819 _+ 140  14,086 _+ 662  2,884 _+ 75  14,276 3= 270 
Mouse (2%)  44 _+ 6  2,747 _+ 33  12,975 _+ 219  2,515 _+ 41  12,277 _+ 345  2,830 _+ 48  13,348 _+ 84 
Human(5%)  71_+10  2,316_+24  14,560+56  2,233_+140  12,033+1058  2,189-+28  13,254_+517 
* RPMI  1640 supplemented with heat-inactivated pooled serum from various sources. 
* Subclone A9.4 (1  ×  10  a cells/culture) was stimulated with syngeneic CB6/FI or parental BALB/c, or C57BL/6 (1  ×  106 
cells/culture). 50 #g/ml KLH was added to cultures. 
! Mean _+ SD of triplicate cultures. 
TABLE  II 
Absorption of Anti-IA Antibodies with Subclone A9.4 Cultured with 
Syngeneic Filler Cells 
Monoclonal antibody  Complement  Absorption*  Percent viable cells* 
Anti-lA  b  -  -  3 _+ 1 
+  -  87_+5 
+  +  10_+5 
Anti-lA  d  -  -  2_+1 
+  -  83_+5 
+  +  12_+5 
Nil  +  -  2  -+  1 
* Absorption experiments were carried out by incubation for 45 min at 37"C of 0.2 
ml of antibody with 106 A9.4 T  cell clones cultured on CB6/FI filler cells. Cb6/Fs 
T-depleted splenic lymphocytes were incubated for 45 min at 37 *C with ascitic fluid 
of monoclonal antibodies specific for I-A  b (1:12,000) and I-A  a (1:20,000), and rabbit 
complement. 
* Cytotoxic activity of anti-Ia antibodies was measured by trypan blue dye exclusion 
on duplicate wells. 
cells independently of the species difference in serum used to supplement the 
culture (Table I). 
Although proliferation to KLH is a  measure of the immunological activation 
and specificity-of subclone A9.4, it does not demonstrate a relationship between 
the helper phenotype and helper function. The helper capacity tested in an in 
vitro antibody synthesis assay by incubation of KLH-primed lymph node cells, 
subclone A9.4,  and clone F6,  with highly purified B cells from trinitrophenyl 
(TNP)-OVA-primed CB6/F1 mice in the presence of TNP-KLH. 
The magnitude of direct  and  indirect anti-TNP  plaque-forming cell  (PFC) 
responses of B cells incubated with clone F6 was consistently higher in comparison 
with lymph node cells derived from KLH-primed CB6/F1  mice. However,  no 
significant  helper  effect  was  detected  with  subclone  A9.4,  tested  four  times 
during an  18 mo period (unpublished results).  These results indicate that sub- 
clone A9.4, despite its ability to proliferate to KLH, is unable to exhibit helper 
function. 
An interesting observation is the ability of this subclone to proliferate to KLH 
in  the presence of irradiated  spleen cells from either parent.  To exclude the 
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TABLE  III 
Inhibition of Subclone A9. 4 Proliferative Response to Stimulator  Cells with Monoclonal Anti-Ia 
Antibodies 
Monoclonal  Percent inhibition with A9.4 subclone cultured 6 wk on: 
antibodies  CB6F~ filler cells  BALB/c filler cells  C57BL6 filler cells 
added during 
the culture  CB6FI*  BALB/c*  C57BL6"  CB6FI*  BALB/c*  C57BL6"  CB6FI*  BALB/c*  C57BL6" 
Anti-Ia  d (MK-D6)  69.4  58.9  65.3  55.9  52.8  32.6  6.6  -6.7 
71.4  69.9  60.8 
69.5  69.9  60.8 
Anti-la  b  49.7  57.7  56.4  6.8  6.6  1.1  68.8  71.1 
83.8  73.4  70.1 
82.7  76.9  70.1 
Anti-Ia  k  -0.4  6.8  -3.7 
(10.2-16)  16  21.0  -0.9 
9.9  2.4  -0.9 
12.1 
77.1 
6.8  -4.2  -7.3  6.5  -2.2  -16.3 
Subclone A9.4 was repeatedly cultured on syngeneic or parental filler cells for 6  wk before assaying for inhibition of 
proliferation to stimulator splenic cells with monoclonal anti-Ia antibodies. All cultures contained Iscove's serum-free 
medium supplemented with 1% affinity-purified monoclonal antibodies. Results are presented as percent inhibition of 
proliferation. Three separate experiments were performed on cells grown as syngeneic CB6/F1 filler cells. 
* Stimulating  cells 
to either parent, the effect of anti-Ia monoclonal antibodies on the proliferative 
response of this clone was studied. The results, presented in Table II, show that 
anti-I-A b and anti-I-A  d monoclonal antibodies inhibited the proliferative response 
of subclone A9.4 to both irradiated parental spleen cells. To determine whether 
these results were due to Ia molecules passively absorbed by A9.4 T  cells from 
the  irradiated  filler cells,  the  following experiment  was performed.  A9.4  cells 
were cultured  for  6  wk with  either  CB6/FI,  BALB/c, or C57BL/6 irradiated 
spleen cells. The  cells harvested from each of these cultures were used to test 
the effect of anti-IA monoclonal antibodies on the proliferative response to CB6/ 
F~, BALB/c, and C57BL/6 irradiated spleen cells. The results presented in Table 
III show that the response of subclone A9.4 cultured on BALB/c filler cells was 
inhibited by anti-I-A d antibodies, but not by anti-I-A  b antibodies. Conversely, the 
proliferative response of this clone cultured on C57BL/6 was inhibited only by 
anti-I-A b and not by anti-I-A d antibodies. These results suggest that the inhibition 
of proliferation of subclone A9.4 by monoclonal anti-I-A antibodies is due to the 
passive absorption of Ia molecules from the filler cells onto the T  cell clone. 
The presence of Ia molecules bound to subclone A9.4 was further substantiated 
in  absorption  experiments.  The  results  illustrated  in  Table  II  show  that  the 
complement-mediated  cytotoxic activity of monoclonal  anti-I-A b and  anti-I-A  d 
antibodies was drastically reduced after incubation with subclone A9.4 cultured 
on CB6/F1.  The cytotoxic activity of both monoclonal antibodies could not be 
absorbed by the T  cell clone after it had been cultured for 7 d in IL-2 without 
any irradiated  filler cells. These data further support the suggestion that anti-I- 
A inhibition is due to the passive absorption of class II molecules onto this clone. 
Indeed, there are recent reports that demonstrate that highly purified, antigen- 
specific T  blasts or T  cell clones (13) can passively bind  Ia determinants  from 
allogeneic or syngeneic feeder cells. 
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TABLE IV 
Mls Reactivity of Subclone A9.4 
309 
Stimulator strain  H-2  MIs 
Exp. 1  Exp. 2 
Nil  KLH  Nil  KLH 
cpm 
Nil  --  --  266 ±  91"  266 ± 97  209 ±  19  130 ±  30 
CB6Ft  b/d  b  1,954 ±  109  4,829 ± 841  3,668 ± 630  13,820 ±  533 
C57BL/6  b  b  1,107 +  77  3,457 ±  137  3,765 ±  805  10,955 ±  777 
BALB/c  d  b  2,173 ±  128  4,632 ± 416  4,768 ±  106  12,607 ±  627 
BALB/B  b  b  1,770 3= 197  3,457 ±  61  ND  ND 
BALB/K  k  b  1,157±119  3,055 ±  364  4,481±272  10,313±980 
BXD: 1  d  b  2,021  ±  148  4,568 ±  302  4,902 ±  197  11,742 ±  1,564 
2  b  a  158±23  209±140  511±116  781±123 
6  d  b  2,267 ±  340  5,070 ±  138  4,413 ±  328  7,541 ±  786 
8  b  a  108 ±  16  148 ±50  593 ±419  378 ±  126 
12  d  b  1,757 ±  128  3,990 ± 97  2,941 ±  786  10,521 ±  1,445 
24  d  a  127 ±  49  381 ±  106  158 ± 67  150 ±  72 
29  b  a  158 ±  12  86 ± 45  248 ±  121  421 ±  55 
B10.D2  d  b  925 ±  71  3,736 ±  341  ND  ND 
AB.Y  b  c  245 ±  145  218 ±  196  ND  ND 
Rlll]J  r  a  188 ±  50  145 ± 93  ND  ND 
CBA/J  k  d  ND  ND  455 ±  55  530 ±  54 
Proliferation of subclone A9.4(104 cells/culture) to syngeneic and allogeneic splenic stimulator cells was carried 
out with 5 x  106 stimulator cells in Exp. 1 and  1 x  106 in Exp. 2. In both experiments, the antigen proliferation 
was carried out with 50 t~g/ml KLH. 
* Mean ±  SD of triplicate cultures. ND, not done. 
genetic restriction is due to molecules encoded outside the MHC. The prolifer- 
ative response of this  clone was therefore tested in the  presence of irradiated 
spleen cells derived from animals of different Mls haplotypes. The rationale of 
this investigation was based on information indicating that BALB/c and C57BL/ 
6  share  the same silent  Mls  b determinants,  and that  Mls gene products induce 
strong T  cell proliferative  responses,  similar to the  I-A gene product.  Data  in 
Table IV show that only stimulator strains which express Mls  b determinants were 
able to induce the proliferative response of subclone A9.4 with KLH. In partic- 
ular, BALB.K (H-2  k, Mls  b) induced proliferation, whereas AB.Y (H-2  b, M!s  c) did 
not.  This  indicates  that  subclone A9.4 can  recognize  KLH in association with 
Mls  determinants.  In  addition  to  the  antigen-specific  proliferation,  this  clone 
showed significant proliferation in the absence of antigen to syngeneic (CB6/F~) 
cells, as well as to both parental  cells (BALB/c and  C57BL/6).  This clone did 
not proliferate,  however,  in  the  presence of irradiated  spleen cells from  mice 
bearing H-2  k, H-2*, H-2', H-2  a, H-2  u, or H-2  q haplotypes (data not shown). 
The  genetic  restriction  of subclone  A9.4  to  MIs  b determinants  is  further 
supported by the results obtained with recombinant inbred (RI) BXD mice. Only 
the recombinant strains that possess chromosome 1 from BALB/c mice and bear 
Mls  b determinants  were able to induce a  proliferative response with or without 
KLH. Interestingly,  the RI BXD 6  strain,  exhibiting a  recombination  in chro- 
mosome 1 and bearing Mls  a determinants, was unable to stimulate the prolifer- 
ation  of A9.4  T  cells.  Therefore,  these  results  suggest  that  this  T  cell  clone 
recognizes autologous determinants  encoded by the  Mls  b allele as  well as  the 
foreign antigen associated with such determinants. 310  MIs-SPECIFIC  T  CLONE 
Discussion 
The aim of this communication has been to characterize a  T  cell clone that 
recognizes antigen in the context of non-MHC determinants. Antigen recogni- 
tion by this T  cell clone was shown to be restricted to determinants encoded by 
the Mls  b allele. The frequency of precursor T  cells specific for syngeneic Mls  b 
determinants appears  to be a  rare event; only one clone out of our panel of 
KLH-specific clones exhibited this pattern of proliferation. While class  I and II 
MHC determinants play a major role in antigen recognition by T  lymphocytes, 
non-MHC determinants may also be involved in regulating this important mech- 
anism of immunological responsiveness. 
Various congeneic and  RI  strains  were used to characterize the autoiogous 
histocompatibility determinants recognized by subclone A9.4. The KLH-induced 
proliferation is independent of classic  MHC determinants, as demonstrated by 
the lack of T  cell activation by AB.Y (H-2  b, Mist). The results using the RI BXD 
strains demonstrate that non-MHC determinants were responsible for the prolif- 
eration of this clone. Four of the strains tested contain recombinations within 
chromosome one. Two strains,  RI  BXD  2  and 8,  containing a  recombination 
between the dipeptidase-1  gene of C57BL/6  and the Mls gene of DBA/2,  did 
not induce proliferation of this clone, whereas strain RI BXD 6, which contains 
a reciprocal recombination between the dipeptidase-1  gene of DNA/2 and the 
Mls  locus  of  C57BL/6,  did  induce  proliferation  of the  T  cell  clone.  The 
implication of these findings is that T  cell clone A9.4 recognizes KLH in  the 
context of syngeneic Mls gene products. 
Critical differences between our KLH-Mls- and KLH-MHC-restricted T  cell 
clones were observed.  First,  the clone that recognizes KLH  in  the context of 
non-MHC gene products does not provide help to TNP-OVA-primed B cells in 
the presence of TNP-KLH to the generation of an anti-TNP response. In con- 
trast,  T  cell clones that demonstrate recognition of KLH- and MHC-encoded 
determinants exhibited  helper activity for both  IgM  and  IgG  responses.  We 
cannot rule out the possibility that other Mls-restricted T  cell clones will be able 
to provide such help. Second, the A9.4 T cell subclone passively binds Ia antigens 
derived from irradiated  filler cells,  since its  proliferative response  to  CB6F1, 
BALB/c, and C57BL/6  stimulatory cells was inhibited with antMa antibodies 
corresponding to filler cell haplotypes. This inhibition may be related to a steric 
hinderance mechanism by which antMa antibodies bound to passively absorbed 
Ia alter the ability of the receptor of A9.4 clones to interact with Mls antigens 
expressed on stimulatory cells. 
The mechanisms by which Ia  binds to  this  T  cell clone are unclear. Other 
investigators have shown that both murine and human activated T cells can bind 
Ia molecules (12-14). There are at least three possible mechanisms for this type 
of binding:  (a)  The  binding  of Ia  molecules may be  due  to  specific  antMa 
receptors. This is unlikely since a single clone binds to both parental haplotypes 
as well as the F~ Ia antigen. (b) Ia molecules may bind to a nonspecific receptor 
for these molecules by mechanisms similar to the binding of the Fc fragments of 
immunogiobulin to the Fc receptor. (c) Ia binding may occur through compli- 
mentary binding of these molecules by the Ia molecules that are expressed on 
activated T  cell clones. These hypotheses are currently under investigation. WATERS, WAKSAL, NORTON, AND  BONA  311 
MHC determinants play a major role in the differentiation and maturation of 
T  iymphocytes. They are also involved in genetically restricted antigen recogni- 
tion during the effector phases of cell-mediated immune responses. It is possible 
that class II MHC molecules which bind to activated T  cells interact in a unique 
way with Mls determinants presented on antigen-presenting cells. The existence 
of a T  cell clone restricted to syngeneic Mls determinants suggests that this locus 
may also play a role during the developmental stages of T  lymphocyte differen- 
tiation. 
Summary 
A  T  cell  clone  isolated  from  antigen-primed  CB6/FI  mice  was  shown  to 
proliferate  to keyhole limpet hemocyanin  (KLH) in  the presence of irradiated 
syngeneic  F1  spleen  cells,  as  well  as  spleen  cells  from  either  parental  strain 
(BALB/c and C57BL/6). The genetic restriction involved in this antigen-specific 
proliferation was mapped using BXD (C57BL/6 ×  DBA/2) recombinant inbred 
strains of mice to the Mls gene on chromosome one. To exclude the role of Ia 
antigens as the restricting determinants,  monoclonal anti-Ia antibodies were used 
to block the in vitro proliferative response of this clone. Although anti-la b and 
anti-Ia d  blocked  the  proliferation  of this  clone  to  KLH  in  the  presence  of 
irradiated spleen cells from either parent, this effect was shown to be dependent 
on Ia molecules passively absorbed by the T  cell clone from the irradiated filler 
cells. 
Since the T  clone expressed Thy-l.2  and  Lyt-1 ÷ differentiation  markers,  its 
helper  activity was compared  with  other  KLH carrier-specific  clones in an  in 
vitro antibody synthesis assay. The Mls-KLH-restricted T  cell clone, in contrast 
to other carrier-specific,  major histocompatibility complex (MHC)-restricted  T 
cell clones, was unable to cooperate with trinitrophenyl (TNP)-primed B cells in 
the presence of TNP-KLH to generate an anti-TNP response. These experiments 
suggest that non-MHC determinants,  such as autologous Mls gene products, may 
play a role in genetically restricted antigen recognition by T  lymphocytes. 
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